跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58 条关于
“PALISADE”
全部
58
临床试验
11
药物
0
机构
1
资讯
46
去年
Plozasiran Shows Promise in Reducing Triglycerides in Familial Chylomicronemia Syndrome and Severe Hypertriglyceridemia
2年前
Palisade Bio Identifies PDE4B as Potential Biomarker for Ulcerative Colitis Patient Stratification
去年
Palisade Bio's PALI-2108 Shows Promise in Ulcerative Colitis Preclinical Studies
去年
Palisade Bio Advances PALI-2108 for Ulcerative Colitis with Phase 1 Trial Imminent
去年
Vistagen Initiates Phase 3 Trial of Fasedienol for Acute Social Anxiety Disorder Treatment
去年
Palisade Bio Registers 8.9M Shares for Resale Amid Financial Challenges and PALI-2108 Development
去年
Palisade Bio Advances PALI-2108 for Ulcerative Colitis Treatment into Multiple Ascending Dose Study
3个月前
Palisade Bio Strengthens Board with Biotech Veterans Baltera and Zwick as PALI-2108 Advances Toward Phase 2 in IBD
2年前
Arrowhead's Plozasiran Receives FDA Breakthrough Therapy Designation for Familial Chylomicronemia Syndrome
去年
Plozasiran Shows Promise in Reducing Triglycerides in Phase 3 and Extension Studies
第 1 页,共 5 页
上一页
下一页